Hochschulschrift
Untersuchungen von rekombinantem Modifizierten Vacciniavirus Ankara zur Verabreichung von Antigenen des West-Nil-Virus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
München, Ludwig-Maximilians-Universität, Diss., 2014
- Classification
-
Landwirtschaft, Veterinärmedizin
- Keyword
-
Impfstoff
Viren
West-Nil-Virus
Ankara
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (when)
-
2014
- Creator
- Contributor
-
Sutter, Gerd
- URN
-
urn:nbn:de:bvb:19-166483
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Kaserer, Martina
- Sutter, Gerd
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Time of origin
- 2014
Other Objects (12)
Untersuchung der Expression von Proteinen des Staupevirus durch das Modifizierte Vacciniavirus Ankara im Hinblick auf die Erstellung von Vakzinekandidaten
Untersuchung rekombinanter Modifizierter Vacciniaviren Ankara hinsichtlich ihrer Eignung als Hendra-Virus-spezifische Impfstoffkandidaten
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Herstellung und Untersuchung rekombinanter Modifizierter Vacciniaviren Ankara zur Expression von Antigenen des Felinen Panleukopenievirus
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Leukocyte trafficking during infection with modified vaccinia virus Ankara : the role of chemokine receptor 1 and complement activation
Characterization of fetal protection by vaccination with recombinant Modified Vaccinia virus Ankara in a Zika virus mouse model
Untersuchung der Expression von Proteinen des Staupevirus durch das Modifizierte Vacciniavirus Ankara im Hinblick auf die Erstellung von Vakzinekandidaten
Untersuchung rekombinanter Modifizierter Vacciniaviren Ankara hinsichtlich ihrer Eignung als Hendra-Virus-spezifische Impfstoffkandidaten
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Herstellung und Untersuchung rekombinanter Modifizierter Vacciniaviren Ankara zur Expression von Antigenen des Felinen Panleukopenievirus
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Leukocyte trafficking during infection with modified vaccinia virus Ankara : the role of chemokine receptor 1 and complement activation
Characterization of fetal protection by vaccination with recombinant Modified Vaccinia virus Ankara in a Zika virus mouse model
Untersuchung der Expression von Proteinen des Staupevirus durch das Modifizierte Vacciniavirus Ankara im Hinblick auf die Erstellung von Vakzinekandidaten
Untersuchung rekombinanter Modifizierter Vacciniaviren Ankara hinsichtlich ihrer Eignung als Hendra-Virus-spezifische Impfstoffkandidaten
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Herstellung und Untersuchung rekombinanter Modifizierter Vacciniaviren Ankara zur Expression von Antigenen des Felinen Panleukopenievirus
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Leukocyte trafficking during infection with modified vaccinia virus Ankara : the role of chemokine receptor 1 and complement activation